Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen
暂无分享,去创建一个
N. Niikawa | M. Aoe | S. Nakamura | L. Old | H. Wada | Shinichiro Nakamura | T. Higashi | H. Kumon | T. Saika | Y. Noguchi | A. Hiraki | T. Ono | E. Nakayama | T. Kurashige | N. Harada | H. Wada | N. Harada | Y. Noguchi | T. Higashi | Motoi Aoe | Shinichiro Nakamura
[1] L. Old,et al. Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: Identification of a cancer/testis antigen , 2000, International journal of cancer.
[2] V. Cerundolo,et al. Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] D. Speiser,et al. Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients. , 2000, Cancer research.
[4] T. Boon,et al. MAGE‐B5, MAGE‐B6, MAGE‐C2, and MAGE‐C3: four new members of the MAGE family with tumor‐specific expression , 2000, International journal of cancer.
[5] D. Jäger,et al. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[6] N. Altorki,et al. Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. , 2000, Cancer letters.
[7] Yao-Tseng Chen,et al. CT10: A new cancer‐testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational‐difference analysis , 2000, International journal of cancer.
[8] D. Jäger,et al. Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma , 2000, The Journal of experimental medicine.
[9] U. Weidle,et al. CTp11, a novel member of the family of human cancer/testis antigens. , 1999, Cancer research.
[10] S. Rosenberg,et al. Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen. , 1999, Science.
[11] S. Rosenberg,et al. Identification of a Novel Major Histocompatibility Complex Class II–restricted Tumor Antigen Resulting from a Chromosomal Rearrangement Recognized by CD4+ T Cells , 1999, The Journal of experimental medicine.
[12] Yao-Tseng Chen,et al. Isoforms of the human PDZ-73 protein exhibit differential tissue expression. , 1999, Biochimica et biophysica acta.
[13] S. Rosenberg,et al. A new era for cancer immunotherapy based on the genes that encode cancer antigens. , 1999, Immunity.
[14] A. Eggermont,et al. Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T Lymphocytes , 1999, The Journal of experimental medicine.
[15] L. Michaux,et al. LAGE‐1, a new gene with tumor specificity , 1998, International journal of cancer.
[16] Yao-Tseng Chen,et al. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[17] Yao-Tseng Chen,et al. Characterization of human colon cancer antigens recognized by autologous antibodies , 1998, International journal of cancer.
[18] M. Pfreundschuh,et al. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[19] Lloyd J. Old,et al. A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens , 1998, The Journal of experimental medicine.
[20] Lloyd J. Old,et al. New Paths in Human Cancer Serology , 1998, The Journal of experimental medicine.
[21] K. Arden,et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. , 1998, Cancer research.
[22] D. Jäger,et al. Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes , 1998, The Journal of experimental medicine.
[23] M. Shimane,et al. Identification and Characterization of BRDT: A Testis-Specific Gene Related to the Bromodomain Genes RING3 andDrosophila fsh ☆ , 1997 .
[24] Y. Fukushima,et al. A 1.2-megabase BAC/PAC contig spanning the 14q13 breakpoint of t(2; 14) in a mirror-image polydactyly patient. , 1997, Genomics.
[25] P. Bruggen,et al. T cell defined tumor antigens , 1997 .
[26] Özlem Türeci,et al. SSX: A multigene family with several members transcribed in normal testis and human cancer , 1997, International journal of cancer.
[27] M. Pfreundschuh,et al. Serological analysis of human tumor antigens: molecular definition and implications. , 1997, Molecular medicine today.
[28] Yao-Tseng Chen,et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[29] H. Rammensee,et al. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. , 1996, Cancer research.
[30] J. Shabanowitz,et al. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins , 1996, The Journal of experimental medicine.
[31] M. Pfreundschuh,et al. Human neoplasms elicit multiple specific immune responses in the autologous host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[32] G. Winberg,et al. Antibodies to LMP2A/2B in EBV-carrying malignancies. , 1995, European journal of cancer.
[33] O. de Backer,et al. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma , 1995, The Journal of experimental medicine.
[34] J. Wharton,et al. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines , 1995, The Journal of Experimental Medicine.
[35] R. Brasseur,et al. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. , 1995, Immunity.
[36] J. Renauld,et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1994, The Journal of experimental medicine.
[37] S. Rosenberg,et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[38] P. Coulie,et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1993, The Journal of experimental medicine.
[39] C. Heyting,et al. A coiled‐coil related protein specific for synapsed regions of meiotic prophase chromosomes. , 1992, The EMBO journal.
[40] P. Chomez,et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.
[41] C. Macleod,et al. A novel oncofetal gene is expressed in a stage-specific manner in murine embryonic development. , 1990, Developmental biology.